Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Armata Pharmaceuticals, Inc. (ARMP) had Income from Continuous Operations of $-16.30M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$2.17M |
|
$-16.30M |
|
-- |
|
$2.17M |
|
$9.01M |
|
$-6.84M |
|
$-9.45M |
|
$-16.30M |
|
$-16.30M |
|
$-16.30M |
|
|
Income from Continuous Operations |
$-16.30M |
$-16.30M |
|
$-16.30M |
|
$-6.84M |
|
$-6.48M |
|
36.19M |
|
36.19M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$7.52M |
|
$12.66M |
|
$73.27M |
|
$80.79M |
|
$120.08M |
|
-- |
|
$30.21M |
|
$150.29M |
|
$-69.50M |
|
$-72.99M |
|
$-69.50M |
|
36.19M |
|
| Cash Flow Statement Financials | |
$-14.79M |
|
$-0.25M |
|
$9.99M |
|
$14.77M |
|
$9.72M |
|
$-5.05M |
|
$1.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.06 |
|
-- |
|
-- |
|
-- |
|
-1.62 |
|
100.00% |
|
-315.54% |
|
-315.54% |
|
-- |
|
-751.27% |
|
-751.27% |
|
$-15.04M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
1.00 |
|
89.96 |
|
23.45% |
|
22.32% |
|
-20.17% |
|
23.45% |
|
$-1.92 |
|
$-0.42 |
|
$-0.41 |
|